Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?

Stephen Lafranchi, James E. Haddow, Joseph G. Hollowell

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

A workshop entitled, "The Impact of Maternal Thyroid Diseases on the Developing Fetus: Implications for Diagnosis, Treatment, and Screening," was held in Atlanta, Georgia, January 12-13, 2004. This paper reports on the individual session that examined thyroid inadequacy during gestation as a risk factor for adverse pregnancy and developmental outcomes. For this session the following papers were presented: "Adverse Pregnancy Outcomes"; "Thyroid Physiology in the Fetus"; "New England Data: Cretinism Revisited-Preventing Fetal Brain Damage when Mothers Have Subclinical Hypothyroidism"; "Dutch Data: Pregnancy, Maternal Thyroid (Dys)function and Outcome of the Offspring"; and "Report on the Wales Controlled Antenatal Thyroid Screening Study (CATS); A Prospective RCT." These presentations were formally discussed by invited respondents well as others in attendance. Salient points from this session about which there was agreement include the following. Maternal hypothyroidism is associated with complications of pregnancy and adverse effects on the fetus. These risks are greater in women with overt hypothyroidism compared to subclinical hypothyroidism, and also appear to be increased in women with euthyroid autoimmune thyroid disease. If maternal hypothyroidism is treated adequately, this appears to reduce the risk for adverse outcomes. The demonstration of a pattern of ontogeny of fetal cerebral cortex deiodinases and thyroid hormone receptors, beginning by 7-8 weeks' gestation, is circumstantial evidence that thyroid hormone plays an important role in fetal neurodevelopment. Significant fetal thyroid hormone production and secretion does not begin until approximately 20 weeks' gestation. If there is a significant role for thyroid hormone in fetal neurodevelopment before 20 weeks' gestation, it likely is of maternal origin. Studies demonstrate low levels of thyroxine in the fetal coelomic fluid and blood prior to 12-14 weeks' gestation. Published data consistently document a relationship between maternal thyroid deficiency during pregnancy and problems with neuropsychological development of the offspring.

Original languageEnglish (US)
Pages (from-to)60-71
Number of pages12
JournalThyroid
Volume15
Issue number1
StatePublished - Jan 2005

Fingerprint

Pregnancy Outcome
Thyroid Gland
Mothers
Hypothyroidism
Pregnancy
Thyroid Hormones
Fetus
Thyroid Diseases
Congenital Hypothyroidism
Thyroid Hormone Receptors
Iodide Peroxidase
New England
Pregnancy Complications
Wales
Prenatal Diagnosis
Thyroxine
Cerebral Cortex
Autoimmune Diseases
Education
Brain

ASJC Scopus subject areas

  • Endocrinology

Cite this

Lafranchi, S., Haddow, J. E., & Hollowell, J. G. (2005). Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? Thyroid, 15(1), 60-71.

Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? / Lafranchi, Stephen; Haddow, James E.; Hollowell, Joseph G.

In: Thyroid, Vol. 15, No. 1, 01.2005, p. 60-71.

Research output: Contribution to journalArticle

Lafranchi, S, Haddow, JE & Hollowell, JG 2005, 'Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?', Thyroid, vol. 15, no. 1, pp. 60-71.
Lafranchi, Stephen ; Haddow, James E. ; Hollowell, Joseph G. / Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?. In: Thyroid. 2005 ; Vol. 15, No. 1. pp. 60-71.
@article{4b15a917facd460494e5ef21969d4de1,
title = "Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?",
abstract = "A workshop entitled, {"}The Impact of Maternal Thyroid Diseases on the Developing Fetus: Implications for Diagnosis, Treatment, and Screening,{"} was held in Atlanta, Georgia, January 12-13, 2004. This paper reports on the individual session that examined thyroid inadequacy during gestation as a risk factor for adverse pregnancy and developmental outcomes. For this session the following papers were presented: {"}Adverse Pregnancy Outcomes{"}; {"}Thyroid Physiology in the Fetus{"}; {"}New England Data: Cretinism Revisited-Preventing Fetal Brain Damage when Mothers Have Subclinical Hypothyroidism{"}; {"}Dutch Data: Pregnancy, Maternal Thyroid (Dys)function and Outcome of the Offspring{"}; and {"}Report on the Wales Controlled Antenatal Thyroid Screening Study (CATS); A Prospective RCT.{"} These presentations were formally discussed by invited respondents well as others in attendance. Salient points from this session about which there was agreement include the following. Maternal hypothyroidism is associated with complications of pregnancy and adverse effects on the fetus. These risks are greater in women with overt hypothyroidism compared to subclinical hypothyroidism, and also appear to be increased in women with euthyroid autoimmune thyroid disease. If maternal hypothyroidism is treated adequately, this appears to reduce the risk for adverse outcomes. The demonstration of a pattern of ontogeny of fetal cerebral cortex deiodinases and thyroid hormone receptors, beginning by 7-8 weeks' gestation, is circumstantial evidence that thyroid hormone plays an important role in fetal neurodevelopment. Significant fetal thyroid hormone production and secretion does not begin until approximately 20 weeks' gestation. If there is a significant role for thyroid hormone in fetal neurodevelopment before 20 weeks' gestation, it likely is of maternal origin. Studies demonstrate low levels of thyroxine in the fetal coelomic fluid and blood prior to 12-14 weeks' gestation. Published data consistently document a relationship between maternal thyroid deficiency during pregnancy and problems with neuropsychological development of the offspring.",
author = "Stephen Lafranchi and Haddow, {James E.} and Hollowell, {Joseph G.}",
year = "2005",
month = "1",
language = "English (US)",
volume = "15",
pages = "60--71",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?

AU - Lafranchi, Stephen

AU - Haddow, James E.

AU - Hollowell, Joseph G.

PY - 2005/1

Y1 - 2005/1

N2 - A workshop entitled, "The Impact of Maternal Thyroid Diseases on the Developing Fetus: Implications for Diagnosis, Treatment, and Screening," was held in Atlanta, Georgia, January 12-13, 2004. This paper reports on the individual session that examined thyroid inadequacy during gestation as a risk factor for adverse pregnancy and developmental outcomes. For this session the following papers were presented: "Adverse Pregnancy Outcomes"; "Thyroid Physiology in the Fetus"; "New England Data: Cretinism Revisited-Preventing Fetal Brain Damage when Mothers Have Subclinical Hypothyroidism"; "Dutch Data: Pregnancy, Maternal Thyroid (Dys)function and Outcome of the Offspring"; and "Report on the Wales Controlled Antenatal Thyroid Screening Study (CATS); A Prospective RCT." These presentations were formally discussed by invited respondents well as others in attendance. Salient points from this session about which there was agreement include the following. Maternal hypothyroidism is associated with complications of pregnancy and adverse effects on the fetus. These risks are greater in women with overt hypothyroidism compared to subclinical hypothyroidism, and also appear to be increased in women with euthyroid autoimmune thyroid disease. If maternal hypothyroidism is treated adequately, this appears to reduce the risk for adverse outcomes. The demonstration of a pattern of ontogeny of fetal cerebral cortex deiodinases and thyroid hormone receptors, beginning by 7-8 weeks' gestation, is circumstantial evidence that thyroid hormone plays an important role in fetal neurodevelopment. Significant fetal thyroid hormone production and secretion does not begin until approximately 20 weeks' gestation. If there is a significant role for thyroid hormone in fetal neurodevelopment before 20 weeks' gestation, it likely is of maternal origin. Studies demonstrate low levels of thyroxine in the fetal coelomic fluid and blood prior to 12-14 weeks' gestation. Published data consistently document a relationship between maternal thyroid deficiency during pregnancy and problems with neuropsychological development of the offspring.

AB - A workshop entitled, "The Impact of Maternal Thyroid Diseases on the Developing Fetus: Implications for Diagnosis, Treatment, and Screening," was held in Atlanta, Georgia, January 12-13, 2004. This paper reports on the individual session that examined thyroid inadequacy during gestation as a risk factor for adverse pregnancy and developmental outcomes. For this session the following papers were presented: "Adverse Pregnancy Outcomes"; "Thyroid Physiology in the Fetus"; "New England Data: Cretinism Revisited-Preventing Fetal Brain Damage when Mothers Have Subclinical Hypothyroidism"; "Dutch Data: Pregnancy, Maternal Thyroid (Dys)function and Outcome of the Offspring"; and "Report on the Wales Controlled Antenatal Thyroid Screening Study (CATS); A Prospective RCT." These presentations were formally discussed by invited respondents well as others in attendance. Salient points from this session about which there was agreement include the following. Maternal hypothyroidism is associated with complications of pregnancy and adverse effects on the fetus. These risks are greater in women with overt hypothyroidism compared to subclinical hypothyroidism, and also appear to be increased in women with euthyroid autoimmune thyroid disease. If maternal hypothyroidism is treated adequately, this appears to reduce the risk for adverse outcomes. The demonstration of a pattern of ontogeny of fetal cerebral cortex deiodinases and thyroid hormone receptors, beginning by 7-8 weeks' gestation, is circumstantial evidence that thyroid hormone plays an important role in fetal neurodevelopment. Significant fetal thyroid hormone production and secretion does not begin until approximately 20 weeks' gestation. If there is a significant role for thyroid hormone in fetal neurodevelopment before 20 weeks' gestation, it likely is of maternal origin. Studies demonstrate low levels of thyroxine in the fetal coelomic fluid and blood prior to 12-14 weeks' gestation. Published data consistently document a relationship between maternal thyroid deficiency during pregnancy and problems with neuropsychological development of the offspring.

UR - http://www.scopus.com/inward/record.url?scp=13544261493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13544261493&partnerID=8YFLogxK

M3 - Article

C2 - 15687825

AN - SCOPUS:13544261493

VL - 15

SP - 60

EP - 71

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 1

ER -